A bispecific fusion protein, ACDClx, can selectively activate T cells against glioblastoma cells in vitroRebecca Cook, Sierra Bichler,Andrew Diamos,Braeden Schaefer, Andrew Niemann,Hugh Mason,Tsafrir Mor,Rachael Sirianni,Joseph BlattmanJOURNAL FOR IMMUNOTHERAPY OF CANCER(2017)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要